| Authors: |
Khambati N; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. Electronic address: nisreen.khambati@stcatz.ox.ac.uk., Song R; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Division of Infectious Diseases, Boston Children's Hospital, Boston, MA USA; Department of Pediatrics, Harvard Medical School, Boston, MA USS., Smith JP; Division of Global HIV and Tuberculosis, Centers for Disease Control and Prevention, Atlanta, Georgia, United States; Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut, United States., Bijker EM; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Department of Pediatrics, Maastricht University Medical Center, MosaKids Children's Hospital, Maastricht, the Netherlands., McCarthy K; Division of Global HIV and Tuberculosis, Centers for Disease Control and Prevention, Atlanta, Georgia, United States., Click ES; Division of Global HIV and Tuberculosis, Centers for Disease Control and Prevention, Atlanta, Georgia, United States., Mchembere W; Kenya Medical Research Institute - Center for Global Health Research, Kisumu, Kenya., Okumu A; Kenya Medical Research Institute - Center for Global Health Research, Kisumu, Kenya., Musau S; Kenya Medical Research Institute - Center for Global Health Research, Kisumu, Kenya., Okeyo E; Kenya Medical Research Institute - Center for Global Health Research, Kisumu, Kenya., Perez-Velez CM; University of Arizona College of Medicine, Tucson, AZ USA., Cain K; Division of Global HIV and Tuberculosis, Centers for Disease Control and Prevention, Atlanta, Georgia, United States. |
